Posted on

bionorica cbd

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

To allow for equitable access to all users, SEC reserves the right to limit requests originating from undeclared automated tools. Your request has been identified as part of a network of automated tools outside of the acceptable policy and will be managed until action is taken to declare your traffic.

More Information

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact [email protected]

Reference ID: 0.5dfd733e.1641990819.92d54e94

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

We are not big enough for the demands on the research programme or the increasing competition. Besides, we have to focus on our core business.

Isn’t the financial power of Bionorica SE sufficient to develop the corresponding potential in the market for medical cannabis itself, especially since Bionorica has a high equity ratio of more than 74 per cent?

The selling price is 225.9 million euros. However, the amount of the sale was not decisive. For several reasons Canopy will be the better home in the future for the cannabis business and the C 3 and Bionorica employees working in this segment.

How high will the proceeds from the sale of the Bionorica cannabis business be?

The growth forecast for the Bionorica core business remains valid.